Citations refer to the original publication, not to a Scieee localized version.
Araujo Fernández, I. (2022). Immune Biomarkers In Peripheral Blood In Patients With HER2 Negative Advanced Breast Cancer Treated With A Chemoimmunotherapy Schedule Based On Pembrolizumab And Gemcitabine. – Translational Substudy Of The PANGEA- Breast Cancer Trial (GEICAM/2015-04). https://idus.us.es/items/ee3c7365-c782-468a-b4e8-b10a356fd7b9
Araujo Fernández, Isabel. Immune Biomarkers In Peripheral Blood In Patients With HER2 Negative Advanced Breast Cancer Treated With A Chemoimmunotherapy Schedule Based On Pembrolizumab And Gemcitabine. – Translational Substudy Of The PANGEA- Breast Cancer Trial (GEICAM/2015-04). 2022. https://idus.us.es/items/ee3c7365-c782-468a-b4e8-b10a356fd7b9.
Araujo Fernández, Isabel. Immune Biomarkers In Peripheral Blood In Patients With HER2 Negative Advanced Breast Cancer Treated With A Chemoimmunotherapy Schedule Based On Pembrolizumab And Gemcitabine. – Translational Substudy Of The PANGEA- Breast Cancer Trial (GEICAM/2015-04). 2022. https://idus.us.es/items/ee3c7365-c782-468a-b4e8-b10a356fd7b9.
Araujo Fernández, I. (2022) Immune Biomarkers In Peripheral Blood In Patients With HER2 Negative Advanced Breast Cancer Treated With A Chemoimmunotherapy Schedule Based On Pembrolizumab And Gemcitabine. – Translational Substudy Of The PANGEA- Breast Cancer Trial (GEICAM/2015-04). Available at: https://idus.us.es/items/ee3c7365-c782-468a-b4e8-b10a356fd7b9.
I. Araujo Fernández, “Immune Biomarkers In Peripheral Blood In Patients With HER2 Negative Advanced Breast Cancer Treated With A Chemoimmunotherapy Schedule Based On Pembrolizumab And Gemcitabine. – Translational Substudy Of The PANGEA- Breast Cancer Trial (GEICAM/2015-04),” 2022. [Online]. Available: https://idus.us.es/items/ee3c7365-c782-468a-b4e8-b10a356fd7b9
@misc{araujofernandez2022immune,
author = {Araujo Fernández, Isabel},
title = {Immune Biomarkers In Peripheral Blood In Patients With HER2 Negative Advanced Breast Cancer Treated With A Chemoimmunotherapy Schedule Based On Pembrolizumab And Gemcitabine. – Translational Substudy Of The PANGEA- Breast Cancer Trial (GEICAM/2015-04)},
year = {2022},
url = {https://idus.us.es/items/ee3c7365-c782-468a-b4e8-b10a356fd7b9}
}
The source metadata has no journal, volume or pages. Add them from the original publication if your citation needs them.
